Press release
Oligonucleotide Therapy Market Size, Share, Growth Trends, Demand And Forecast To 2033
Oligonucleotide Therapy Market
As per the report, the oligonucleotide therapy market size has grown rapidly in recent years. It will grow from $4.9 billion in 2023 to $5.61 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The oligonucleotide therapy market size is expected to see rapid growth in the next few years. It will grow to $8.75 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp
Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oligonucleotide therapy market during the forecast period. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in cancer incidence rates globally is anticipated to boost demand for the oligonucleotide therapy market over the forthcoming years.
Innovative Oligonucleotide Therapy Advancements Pioneering Patient-Centric Solutions
The developers and providers of the oligonucleotide therapy market are investing in research and development to remodel the design of therapy to reduce its side effects on patients. The new and innovative oligonucleotides allow for precision medicine approaches and can be designed to selectively target any gene with minimal side effects. It also helps in targeting patient-specific sequences that are causative of rare diseases. In April 2023, the FDA approved Qalsody, an antisense oligonucleotide (ASO), for the treatment of patients with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene. Qalsody targets SOD1 mRNA to reduce the synthesis of SOD1 protein
The oligonucleotide therapy market covered in this report is segmented -
1) By Type: Antisense Oligonucleotide, Aptamer, Other Types
2) By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Other End-User
3) By End User: Hospitals, Research Institutes
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=3398&type=discount
Major companies operating in the oligonucleotide therapy market report are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Gelead Sciences Inc., BioNTech SE, Moderna Inc., Biogen Inc., Bausch + Lomb Company, Jazz Pharmaceuticals plc, QIAGEN Company, Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Dynavax Technologies Corp., Ionis Pharmaceuticals Inc., Akcea Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals lnc., SomaGenics Inc., Wave Life Sciences Ltd., Exicure Inc., Hepion Phrmaceuticals lnc., Avidity Biosciences lnc., Miragen Therapeuutics Inc., ProQR Therapeutics NV, Regulus Therapeutics Inc., PCI Biotech Holdings ASA, Kastle Therapeutics LLC, Santaris Pharma A/S, InteRNA Technologies B.V., Dynacure S.A., Arcturus Therapeutics Holdings Inc., Intellia Therapeutics Inc., Regeneron Pharmaceuticals Inc., Editas Medicine Inc., Evox Therapeutics Ltd., ONK Therapeutics Ltd., PepGen Ltd.
Contents of the report:
1. Executive Summary
2. Oligonucleotide Therapy Market Report Structure
3. Oligonucleotide Therapy Market Trends And Strategies
4. Oligonucleotide Therapy Market - Macro Economic Scenario
5. Oligonucleotide Therapy Market Size And Growth
…..
27. Oligonucleotide Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oligonucleotide Therapy Market Size, Share, Growth Trends, Demand And Forecast To 2033 here
News-ID: 3581438 • Views: …
More Releases from The Business research company
Key Strategic Developments and Emerging Changes Shaping the Carbon Black Market …
The carbon black market is poised for significant expansion over the coming years, driven by multiple factors spanning various industries. This overview delves into the market's growth prospects, leading players, emerging trends, and key segments shaping its future trajectory.
Expected Growth and Market Size of the Carbon Black Market by 2030
The carbon black market is projected to experience robust growth, reaching a valuation of $30.85 billion by 2030. This…
Leading Companies Fueling Growth and Innovation in the Calcium Hypochlorite Mark …
The calcium hypochlorite market is on track for significant expansion over the coming years, driven by various factors linked to environmental regulations and public health. As awareness around water safety and hygiene rises globally, this sector is gaining momentum, offering promising prospects for stakeholders. Let's delve into the market's size, key players, emerging trends, and main segments shaping its future.
Projected Market Size and Growth Trajectory of the Calcium Hypochlorite Market…
Outlook on the Building and Construction Tapes Market: Major Segments, Strategic …
The building and construction tapes industry is positioned for significant expansion in the coming years, driven by ongoing advancements and rising demands in the construction sector. As infrastructure projects evolve and sustainable building practices gain traction, this market is set to experience steady growth through 2030. Below, we explore the market's size projections, key players, emerging trends, and detailed segmentation to provide a clear understanding of its future trajectory.
Building and…
Segment Analysis and Major Growth Areas in the Blue Ammonia Market
The blue ammonia market is poised for significant expansion over the coming years, driven by a growing emphasis on clean energy and decarbonization efforts. As industries seek sustainable alternatives and invest in advanced technologies, blue ammonia is emerging as a key player in the transition toward a low-carbon future. Here's a detailed look at its market size, influential companies, evolving trends, and important segments shaping its trajectory.
Blue Ammonia Market Size…
More Releases for Oligonucleotide
Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period…
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from…
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease…
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User
(Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According…
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis…
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Agilent Technologies
Biosearch Technologies
Eurofins Genomics
Eurogentec
Integrated DNA Technologies
Merck KGAA
Thermo Fisher Scientific
GeneDesign
Bio-Synthesis - CRO/CMO Life Sciences Company
Bioautomation
GE Healthcare
LGC Biosearch Technologies
NITTO Denko Avecia
For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022
Market segment by Regions/Countries, this report…
